EUVIMEDEUVIMED entdecken
Crossref

Does belatacept provide equivalent suppression of acute renal transplant rejection to ciclosporin?

Mohamed H Sayegh, Anil Chandraker

Nature Clinical Practice Nephrology · 2006-03 · 2 (3) · 134-135

DOI: 10.1038/ncpneph0125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature Clinical Practice Nephrology, 2006-03. Verfasst von Mohamed H Sayegh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Transplantation Medicine, Harvard Medical Schooland Brigham and Women's Hospital and Children's Hospital, Boston, MA 02115, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Transplantation Medicine, Harvard Medical Schooland Brigham and Women's Hospital and Children's Hospital, Boston, MA 02115, USA.

Zitieren

APA

Sayegh, M. H., & Chandraker, A. (2006). Does belatacept provide equivalent suppression of acute renal transplant rejection to ciclosporin?. Nature Clinical Practice Nephrology, 2(3), 134-135. https://doi.org/10.1038/ncpneph0125

Vancouver

Sayegh MH, Chandraker A. Does belatacept provide equivalent suppression of acute renal transplant rejection to ciclosporin?. Nature Clinical Practice Nephrology. 2006;2(3):134-135. doi:10.1038/ncpneph0125

BibTeX
@article{Sayegh2006,
  author = {Sayegh, Mohamed H and Chandraker, Anil},
  title = {Does belatacept provide equivalent suppression of acute renal transplant rejection to ciclosporin?},
  journal = {Nature Clinical Practice Nephrology},
  year = {2006},
  volume = {2},
  number = {3},
  pages = {134--135},
  doi = {10.1038/ncpneph0125}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche